The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Elantan 20 mg Tablets

Merus Labs Luxco II S.à.R.L. PA2118/002/003

Main Information

Trade NameElantan 20 mg Tablets
Active SubstancesIsosorbid-5-mononitrat
Dosage FormTablet
Licence HolderMerus Labs Luxco II S.à.R.L.
Licence NumberPA2118/002/003

Group Information

ATC CodeC01DA Organic nitrates
C01DA14 isosorbide mononitrate


License statusAuthorised
Licence Issued21/04/1983
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back